Cargando…

Applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid

BACKGROUND: The cerebrospinal fluid (CSF) culture is a widely used method for the diagnosis of meningitis, but its detection sensitivity is low. Several new methods have been developed for pathogen detection, including metagenomic next-generation sequencing (mNGS) and pathogen-targeted NGS (ptNGS)....

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Daiquan, Hu, Yongqiang, Jiang, Xuebin, Pu, Hao, Guo, Zhendong, Zhang, Yunzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667110/
https://www.ncbi.nlm.nih.gov/pubmed/34988184
http://dx.doi.org/10.21037/atm-21-5488
_version_ 1784614332336701440
author Gao, Daiquan
Hu, Yongqiang
Jiang, Xuebin
Pu, Hao
Guo, Zhendong
Zhang, Yunzhou
author_facet Gao, Daiquan
Hu, Yongqiang
Jiang, Xuebin
Pu, Hao
Guo, Zhendong
Zhang, Yunzhou
author_sort Gao, Daiquan
collection PubMed
description BACKGROUND: The cerebrospinal fluid (CSF) culture is a widely used method for the diagnosis of meningitis, but its detection sensitivity is low. Several new methods have been developed for pathogen detection, including metagenomic next-generation sequencing (mNGS) and pathogen-targeted NGS (ptNGS). In this study, we aimed to evaluate the performance of ptNGS in pathogen detection in CSF. METHODS: CSF specimens were acquired from 38 patients with meningitis who were diagnosed at Xuanwu Hospital, Capital Medical University between October 2020 and February 2021. DNA was extracted from the CSF samples, and pathogens were identified using both ptNGS and mNGS. SPSS 22.0 software was used to compare the pathogen detection performance of ptNGS and mNGS in CSF. RESULTS: Among the 38 patients with meningitis, 14 had a non-infectious disease (NID) and 24 had an infectious disease (ID). Of the 38 samples, both ptNGS and mNGS detected 9 (23.7%) positive samples, and 12 (31.6%) negative samples. Thirteen (34.2%) samples were detected to be positive by ptNGS only, and 4 (10.5%) were detected to be positive by mNGS only. The positivity rate detected by ptNGS for the ID group was higher than that detected by mNGS (P=0.080), and the positivity rates detected by ptNGS and mNGS for the NID group were comparable. The positive predictive value (PPV) and negative predictive value (NPV) of diagnosing an ID by ptNGS were 77.3% and 56.3%, respectively. While, the PPV and NPV of diagnosing an ID by mNGS were 76.9% and 44.0%, respectively. ptNGS increased the sensitivity rate by approximately 70%. The sensitivity rate of ptNGS was higher than that of mNGS (70.8% vs. 41.7%), while the specificity rate of mNGS was higher than that of ptNGS (78.6% vs. 64.3%). Additionally, ptNGS required a shorter time for pathogen diagnosis (15 vs. 24 hrs) and had lower costs than mNGS. CONCLUSIONS: ptNGS has a number of advantages over mNGS, including its sensitivity, timeliness, and economy, all factors that are important considerations in clinical use.
format Online
Article
Text
id pubmed-8667110
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-86671102022-01-04 Applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid Gao, Daiquan Hu, Yongqiang Jiang, Xuebin Pu, Hao Guo, Zhendong Zhang, Yunzhou Ann Transl Med Original Article BACKGROUND: The cerebrospinal fluid (CSF) culture is a widely used method for the diagnosis of meningitis, but its detection sensitivity is low. Several new methods have been developed for pathogen detection, including metagenomic next-generation sequencing (mNGS) and pathogen-targeted NGS (ptNGS). In this study, we aimed to evaluate the performance of ptNGS in pathogen detection in CSF. METHODS: CSF specimens were acquired from 38 patients with meningitis who were diagnosed at Xuanwu Hospital, Capital Medical University between October 2020 and February 2021. DNA was extracted from the CSF samples, and pathogens were identified using both ptNGS and mNGS. SPSS 22.0 software was used to compare the pathogen detection performance of ptNGS and mNGS in CSF. RESULTS: Among the 38 patients with meningitis, 14 had a non-infectious disease (NID) and 24 had an infectious disease (ID). Of the 38 samples, both ptNGS and mNGS detected 9 (23.7%) positive samples, and 12 (31.6%) negative samples. Thirteen (34.2%) samples were detected to be positive by ptNGS only, and 4 (10.5%) were detected to be positive by mNGS only. The positivity rate detected by ptNGS for the ID group was higher than that detected by mNGS (P=0.080), and the positivity rates detected by ptNGS and mNGS for the NID group were comparable. The positive predictive value (PPV) and negative predictive value (NPV) of diagnosing an ID by ptNGS were 77.3% and 56.3%, respectively. While, the PPV and NPV of diagnosing an ID by mNGS were 76.9% and 44.0%, respectively. ptNGS increased the sensitivity rate by approximately 70%. The sensitivity rate of ptNGS was higher than that of mNGS (70.8% vs. 41.7%), while the specificity rate of mNGS was higher than that of ptNGS (78.6% vs. 64.3%). Additionally, ptNGS required a shorter time for pathogen diagnosis (15 vs. 24 hrs) and had lower costs than mNGS. CONCLUSIONS: ptNGS has a number of advantages over mNGS, including its sensitivity, timeliness, and economy, all factors that are important considerations in clinical use. AME Publishing Company 2021-11 /pmc/articles/PMC8667110/ /pubmed/34988184 http://dx.doi.org/10.21037/atm-21-5488 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Gao, Daiquan
Hu, Yongqiang
Jiang, Xuebin
Pu, Hao
Guo, Zhendong
Zhang, Yunzhou
Applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid
title Applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid
title_full Applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid
title_fullStr Applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid
title_full_unstemmed Applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid
title_short Applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid
title_sort applying the pathogen-targeted next-generation sequencing method to pathogen identification in cerebrospinal fluid
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667110/
https://www.ncbi.nlm.nih.gov/pubmed/34988184
http://dx.doi.org/10.21037/atm-21-5488
work_keys_str_mv AT gaodaiquan applyingthepathogentargetednextgenerationsequencingmethodtopathogenidentificationincerebrospinalfluid
AT huyongqiang applyingthepathogentargetednextgenerationsequencingmethodtopathogenidentificationincerebrospinalfluid
AT jiangxuebin applyingthepathogentargetednextgenerationsequencingmethodtopathogenidentificationincerebrospinalfluid
AT puhao applyingthepathogentargetednextgenerationsequencingmethodtopathogenidentificationincerebrospinalfluid
AT guozhendong applyingthepathogentargetednextgenerationsequencingmethodtopathogenidentificationincerebrospinalfluid
AT zhangyunzhou applyingthepathogentargetednextgenerationsequencingmethodtopathogenidentificationincerebrospinalfluid